Publications in collaboration with researchers from Universidade de Vigo (32)

2024

  1. An Injectable Composite Co-Assembled Dehydropeptide-Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy

    Advanced Functional Materials, Vol. 34, Núm. 38

  2. Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia

    Schizophrenia Research, Vol. 270, pp. 260-272

  3. Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

    Neural Regeneration Research, Vol. 19, Núm. 8, pp. 1617-1677

  4. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System

    Nutrients, Vol. 15, Núm. 14

  2. MiRNA Differences Related to Treatment-Resistant Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  3. Proteomic analysis of exosomes derived from human mature milk and colostrum of mothers with term, late preterm, or very preterm delivery

    Analytical Methods, Vol. 15, Núm. 37, pp. 4905-4917

2022

  1. Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases

    International journal of molecular sciences, Vol. 23, Núm. 17

  2. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 6, pp. 1921-1932

  3. Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients

    Frontiers in Pharmacology, Vol. 13

  4. Inteligencia emocional y síndrome de burnout en docentes de grado en enfermería de la Universidad de Vigo 2020

    III Congreso Interdisciplinar de Jóvenes Investigadores 23 y 24 de septiembre de 2021

  5. Tuning the drug multimodal release through a co-assembly strategy based on magnetic gels

    Nanoscale, Vol. 14, Núm. 14, pp. 5488-5500

2021

  1. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

  2. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 125-138

  3. The role of the second extracellular loop of norepinephrine transporter, neurotrophin-3 and tropomyosin receptor kinase C in T cells: A peripheral biomarker in the etiology of schizophrenia

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  4. Voices 2: Improving Prosodic Recognition in Schizophrenia With an Online Rehabilitation Program

    Frontiers in Psychology, Vol. 12

2020

  1. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

    Frontiers in Psychiatry, Vol. 11

  2. Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer’s disease

    Scientific Reports, Vol. 10, Núm. 1

  3. Brainwaves Oscillations as a Potential Biomarker for Major Depression Disorder Risk

    Clinical EEG and Neuroscience, Vol. 51, Núm. 1, pp. 3-9

  4. Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia

    Scientific Reports, Vol. 10, Núm. 1